Cleared Special

K161986 - SIDEKICK and USHER Support Catheters

K161986 is the FDA 510(k) clearance for SIDEKICK and USHER Support Catheters by Bard Peripheral Vascular, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 16-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2016
Decision
16d
Days
Class 2
Risk

K161986 is an FDA 510(k) clearance for the SIDEKICK and USHER Support Catheters. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Bard Peripheral Vascular, Inc. (Tempe, US). The FDA issued a Cleared decision on August 4, 2016 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bard Peripheral Vascular, Inc. devices

Submission Details

510(k) Number K161986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2016
Decision Date August 04, 2016
Days to Decision 16 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 125d · This submission: 16d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 467
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K161986.
Twin-Pass Torque
K162467 · Vascular Solutions, Inc. · Feb 2017
YOGA Microcatheter
K162563 · Codman & Shurtleff, Inc. · Jan 2017
ASAHI Corsair Pro
K161126 · Asahi Intecc Co., Ltd. · Aug 2016
ASAHI Corsair Armet
K161362 · Asahi Intecc Co., Ltd. · Jun 2016
ASAHI Corsair Armet
K152249 · Asahi Intecc Co., Ltd. · Mar 2016
ASAHI Caravel
K152447 · Asahi Intecc Co., Ltd. · Jan 2016